Rim, J., Weber, J., Neely, M., Kelly, F., Nagler, A., Eason, L., … Todd, J. (2024). Early Posttransplant Bronchoalveolar Lavage Fluid (BALF) Hyaluronan is an Independent Risk Marker for Chronic Lung Allograft Dysfunction (CLAD). The Journal of Heart and Lung Transplantation, 43(4), S48–S49. https://doi.org/10.1016/j.healun.2024.02.098

Rim, J., J. Weber, M. Neely, F. Kelly, A. Nagler, L. Eason, P. McArthur, et al. “Early Posttransplant Bronchoalveolar Lavage Fluid (BALF) Hyaluronan is an Independent Risk Marker for Chronic Lung Allograft Dysfunction (CLAD).” The Journal of Heart and Lung Transplantation 43, no. 4 (April 1, 2024): S48–49. https://doi.org/10.1016/j.healun.2024.02.098.

Rim J, Weber J, Neely M, Kelly F, Nagler A, Eason L, et al. Early Posttransplant Bronchoalveolar Lavage Fluid (BALF) Hyaluronan is an Independent Risk Marker for Chronic Lung Allograft Dysfunction (CLAD). The Journal of Heart and Lung Transplantation. 2024 Apr 1;43(4):S48–9.

Rim, J., et al. “Early Posttransplant Bronchoalveolar Lavage Fluid (BALF) Hyaluronan is an Independent Risk Marker for Chronic Lung Allograft Dysfunction (CLAD).” The Journal of Heart and Lung Transplantation, vol. 43, no. 4, Elsevier, Apr. 2024, pp. S48–49. Manual, doi:10.1016/j.healun.2024.02.098.

Rim J, Weber J, Neely M, Kelly F, Nagler A, Eason L, McArthur P, Belperio J, Budev M, Reynolds J, Shah P, Singer L, Snyder L, Palmer S, Todd J. Early Posttransplant Bronchoalveolar Lavage Fluid (BALF) Hyaluronan is an Independent Risk Marker for Chronic Lung Allograft Dysfunction (CLAD). The Journal of Heart and Lung Transplantation. Elsevier; 2024 Apr 1;43(4):S48–S49.